Lim YS - Search Results

1

Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial.

Song DS, Kim W, Ahn SH, Yim HJ, Jang JY, Kweon YO, Cho YK, Kim YJ, Hong GY, Kim DJ, Jung YK, Sohn JH, Lee JW, Park SJ, Lee BS, Kim JH, Kim HS, Yoon SK, Kim MY, Lee KS, Lim YS, Lee WS, Yang JM, Kim KH, Han KH, Um SH. Song DS, et al. Among authors: lim ys. Clin Mol Hepatol. 2021 Apr;27(2):346-359. doi: 10.3350/cmh.2020.0307. Epub 2021 Jan 25. Clin Mol Hepatol. 2021. PMID: 33493393 Free PMC article. Clinical Trial.

2

Current antiviral therapy for chronic hepatitis B.

Lim YS, Suh DJ. Lim YS, et al. J Korean Med Sci. 2004 Aug;19(4):489-94. doi: 10.3346/jkms.2004.19.4.489. J Korean Med Sci. 2004. PMID: 15308835 Free PMC article. Review.

3

Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus.

Kim KM, Choi WB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Kim KM, et al. Among authors: lim ys. J Korean Med Sci. 2005 Oct;20(5):821-8. doi: 10.3346/jkms.2005.20.5.821. J Korean Med Sci. 2005. PMID: 16224157 Free PMC article. Clinical Trial.

4

Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.

Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Chung YH, Lee YS, Yoo W, Kim SO. Lee YS, et al. Among authors: lim ys. Hepatology. 2006 Jun;43(6):1385-91. doi: 10.1002/hep.21189. Hepatology. 2006. PMID: 16729316

5

Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006.

Yun H, Kim S, Lee H, Byun KS, Kwon SY, Yim HJ, Lim YS, Jeong SH, Jee Y. Yun H, et al. Among authors: lim ys. J Med Virol. 2008 May;80(5):777-84. doi: 10.1002/jmv.21127. J Med Virol. 2008. PMID: 18360890

6

The global impact of hepatic fibrosis and end-stage liver disease.

Lim YS, Kim WR. Lim YS, et al. Clin Liver Dis. 2008 Nov;12(4):733-46, vii. doi: 10.1016/j.cld.2008.07.007. Clin Liver Dis. 2008. PMID: 18984463 Review.

7

Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.

Lee YS, Chung YH, Kim JA, Kim SE, Shin JW, Kim KM, Lim YS, Park NH, Lee HC, Lee YS, Suh DJ. Lee YS, et al. Among authors: lim ys. Liver Int. 2009 Apr;29(4):552-6. doi: 10.1111/j.1478-3231.2008.01882.x. Liver Int. 2009. PMID: 19323782

8

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS. Shim JH, et al. Among authors: lim ys. Hepatology. 2009 Oct;50(4):1064-71. doi: 10.1002/hep.23145. Hepatology. 2009. PMID: 19637288 Clinical Trial.

9

Assessment of the efficacy of reducing peginterferon alpha-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C.

Kwon JH, Bae SH, Choi JY, Yoon SK, Byun KS, Paik SW, Lim YS, Lee HC, Han KH, Lee KS. Kwon JH, et al. Among authors: lim ys. Korean J Intern Med. 2009 Sep;24(3):203-11. doi: 10.3904/kjim.2009.24.3.203. Epub 2009 Aug 26. Korean J Intern Med. 2009. PMID: 19721856 Free PMC article.

10

Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.

Shim JH, Lee HC, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ. Shim JH, et al. Among authors: lim ys. J Hepatol. 2010 Feb;52(2):176-82. doi: 10.1016/j.jhep.2009.11.007. Epub 2009 Dec 16. J Hepatol. 2010. PMID: 20006394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

805 results

Search Page